How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,649 results for

Thyroid Function Summary

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Correlation Between Different Levels of Thyroid Peroxidase Antibody and Postpartum Thyroiditis in Early Pregnancy

Identifier: NCT03641638 Recruitment Status : Recruiting First Posted : August 22, 2018 Last Update Posted : August 23, 2018 See Sponsor: China National Nuclear Corporation 416 Hospital Information provided by (Responsible Party): BO Ren, China National Nuclear Corporation 416 Hospital Study Details Study Description Go to Brief Summary: At present, attention to thyroid disease during pregnancy is increasing at home and abroad, but there is relatively little concern about postpartum thyroid disease (...) dysfunction. Condition or disease Postpartum Thyroiditis Detailed Description: First pregnant women who between the ages of 18 to 35 years old and normal thyroid function before pregnancy were selected. Recruit 300 pregnant women who early pregnancy (1-12 weeks of pregnancy) screening TPOAb positive and normal Free triiodothyronine (FT3), normal free thyroxine (FT4) ,Thyroid Stimulating Hormone (TSH) <4.78mIU / L as the observation group. They will be divided into low-level group (TPOAb at 34-102 IU/ml

2018 Clinical Trials

42. NKX2.5 is expressed in papillary thyroid carcinomas and regulates differentiation in thyroid cells. (PubMed)

carcinoma (PTC) patients. Then, the long-term prognostic value of NKX2.5 and its correlation with clinicopathologic features of 51 PTC patients was evaluated in a cohort with 10-years follow-up (1990-1999). Besides, the effect of NKX2.5 overexpression on thyroid differentiation markers and function was also investigated in a non-tumor thyroid cell line (PCCL3).NKX2.5 was shown to be expressed in most PTC samples (8/10, case series; 27/51, cohort). Patients who had tumors expressing NKX2.5 showed lower (...) rates of persistence/recurrence (p = 0.013). Overexpression of NKX2.5 in PCCL3 cells led to: 1) downregulation of thyroid differentiation markers (thyrotropin receptor, thyroperoxidase and sodium-iodide symporter); 2) reduced iodide uptake; 3) increased extracellular H2O2 generation, dual oxidase 1 mRNA levels and activity of DuOx1 promoter.In summary, NKX2.5 is expressed in most PTC samples analyzed and its presence correlates to better prognosis of PTC. In vitro, NKX2.5 overexpression reduces

Full Text available with Trip Pro

2018 BMC Cancer

43. nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer (PubMed)

nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer nc886 is a recently identified cellular non-coding RNA and its depletion leads to acute cell death via PKR (Protein Kinase RNA-activated) activation. nc886 expression is increased in some malignancies, but silenced in others. However, the precise role of nc886/PKR is controversial: is it a tumor suppressor or an oncogene? In this study, we have clarified the role of nc886 in thyroid cancer (...) is associated with poor survival confirmed by data from total of 505 thyroid cancer patients in the Caner Genome Atlas project. Also, the nc886 expression level tends to be elevated and in more aggressively metastatic tumor specimens from thyroid cancer patients. In summary, we have discovered nc886's tumor-promoting role in thyroid cancer which has been concealed by the PKR-mediated acute cell death.

Full Text available with Trip Pro

2016 Oncotarget

44. Thyroid Function and Diabetes Complications

Study Description Go to Brief Summary: The purpose of this study is to investigate the potential association between thyroid function and diabetes complications in the elderly subjects with type 2 diabetes mellitus (T2DM). Condition or disease Intervention/treatment Diabetes Thyroid Disease Other: no intervention Detailed Description: Aims: We investigated the potential association between thyroid parameters and microalbuminuria in the euthyroid elderly subjects with type 2 diabetes mellitus (T2DM (...) Thyroid Function and Diabetes Complications Thyroid Function and Diabetes Complications - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Thyroid Function and Diabetes Complications The safety and scientific

2016 Clinical Trials

45. Cognitive Functions During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma

Cognitive Functions During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma Cognitive Functions During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. Cognitive Functions During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02665325 Recruitment Status : Unknown Verified June 2016 by The Affiliated

2016 Clinical Trials

46. Thyroid hormone receptor beta (THRB) gene testing in resistance to thyroid hormone (RTH)

-stimulating hormone (TSH). The activity of thyroid hormone, which functions in growth, development, and the regulation of body metabolism, is mediated by thyroid hormone receptor alpha (THRA) and thyroid hormone receptor beta (THRB). RTH most often results from deleterious variants in the THRB gene, which is located on chromosome 3 at band p24.3 and encodes a liganddependent transcription factor. In the vast majority of cases, THRB-related RTH is inherited in an autosomal dominant manner. However (...) the secretion and activity of TSH. Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Genetic Testing; Thyroid Hormone Receptors betas Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32013000118

2013 Health Technology Assessment (HTA) Database.

47. Diabetes Agents ? Outcome Comparison Summary Table

Diabetes Agents ? Outcome Comparison Summary Table ANTI-HYPERGLYCEMIC DIABETES AGENTS in T2DM: Outcomes Comparison Summary Table L Regier BSP BA, M LeBras PharmD, J Bareham BSP, L Lu BSP © www.RxFiles.ca Feb 2019 Drug Class Sulfonylureas TZDs Meglitinides DDP-4 Inhibitors GLP-1 Agonists (Subcut) SGLT-2 Inhibitors Insulin in T2DM Generic ? BRAND Metformin (MF) GLUCOPHAGE, GLYCON Gliclazide DIAMICRON Glyburide DIABETA Pioglitazone ACTOS Rosiglitazone AVANDIA Acarbose GLUCOBAY Repaglinide (...) dysfx (? lactic acidosis); may ? B12. 1 st line for obese T2DM (UKPDS-34) Used in combination with metformin (ADVANCE) Caution: ? renal function (& older adults) X FDA +/- HC warnings: 35 ? ? HF (see above), ? ? fractures ? (NNH~30/~3.5 y) ? ? macular edema (conflicting data) Pio:? ? bladder ca >12 mos (27.5 excess /100,000 person yrs), avoid co-admin with dapaglifozin 36 Rosi: Restricted access in CDN (SK-EDS) ( ? CV risk concerns) 37 ? ? PPG, Possible benefit of laxative effect in some ? ? PPG

2013 RxFiles

48. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies (...) . By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society , MD, PhD, FACC , MD, MACC, FAHA , MD, FACC, FAHA , MD, FACC, FAHA, FHRS , MD, FACC , MD, FACC , MD, FACC, FHRS , MD, PhD, FAHA , MB, ChB

2014 American Heart Association

49. Treating subclinical thyroid dysfunction in pregnancy probably has no benefit

-eclampsia, preterm birth, birth weight, neonatal intensive care admission, miscarriage or stillbirth. What does current guidance say on this issue? There is no UK guidance to screen for hypothyroidism from the National Screening Committee or in the NICE antenatal guideline. Nor is there guidance to treat sub-clinical hypothyroidism NICE Clinical Knowledge Summaries outline various criteria for testing thyroid function for women who are pregnant or planning a pregnancy. This includes testing for those (...) weight, neonatal intensive care admission, miscarriage or stillbirth. What does current guidance say on this issue? There is no UK guidance to screen for hypothyroidism from the National Screening Committee or in the NICE antenatal guideline. Nor is there guidance to treat sub-clinical hypothyroidism NICE Clinical Knowledge Summaries outline various criteria for testing thyroid function for women who are pregnant or planning a pregnancy. This includes testing for those over 30 years of age

2018 NIHR Dissemination Centre

50. AACE/ACE/AME Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules

encourage medical professionals to use this information in conjunction with their best clinical judgment. Any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances and preference. Copyright © 2016 AACE.2 Thyroid Nodule Management, Endocr Pract. 2016;22(Suppl 1) Abbreviations: AACE = American Association of Clinical Endocrinologists; ACE = American College of Endocrinology; AFTN = autonomously function- ing thyroid nodule; AME (...) (see Methods). The basis of thyroid nodule management is the use of high-resolution ultrasonography (US), sensitive thyrotro- pin (TSH, formerly thyroid-stimulating hormone) assay, and fine-needle aspiration (FNA) biopsy, together with clinical findings. Thyroid scintigraphy is not necessary for diagnosis in most cases; however, it may be warranted in patients with a low serum TSH value or a multinodu- lar gland to detect functional autonomy, most common in iodine-deficient areas. Measurement

2016 American Association of Clinical Endocrinologists

51. Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer

anticancer drugs. Due to the scarcity of data on the functioning of thyroid gland during chemotherapy in a large scale group, the present study was aimed to investigate the incidence of thyroid abnormity in Chinese women with newly diagnosed breast cancer, and also the effects of chemotherapy on thyroid gland functions or structure in these breast cancer patients undergoing at least four cycles of chemotherapy. Condition or disease Intervention/treatment Breast Cancer Female Thyroid Gland Drug (...) with breast cancer [ Time Frame: 1 week around the indicated detection point ] Rate of thyroid function (measured by chemiluminescence methods) or structure (measured by ultrasonic imaging) abnormity at the time of diagnosis and during chemotherapeutic period will be reported. Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study

2017 Clinical Trials

52. Thyroid Function Summary

Thyroid Function Summary Thyroid Function Summary Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Thyroid Function Summary Thyroid (...) Function Summary Aka: Thyroid Function Summary II. Findings: Hyperthyroidism Increased (T4) and (T3) (fT4) and (fT3) ( ) and (FTI) (rT3) Decreased (TSH) (TRH) III. Findings: Hypothyroidism Increased (TSH) (TRH) Decreased (T4) and (T3) (fT4) and (fT3) ( ) and (FTI) (rT3) IV. References Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Thyroid Function Summary." Click on the image (or right click) to open the source website in a new

2015 FP Notebook

53. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline

Institutes of Health (NIH) criteria and require two of three key features: oligo- or anovulation, clinical and/or biochemical hyperandrogenism and polycystic ovaries on ultrasound (Figure 2). However, as noted, PCOS phenotypes vary widely depending on life stage, genotype, ethnicity and environmental factors, including lifestyle and body weight. Diagnostic investigations must exclude other causes and include thyroid function tests and prolactin and follicle-stimulating hormone (FSH) levels. For diagnosis (...) Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login Purchase options Connect person_outline Login

2011 MJA Clinical Guidelines

54. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline

Institutes of Health (NIH) criteria and require two of three key features: oligo- or anovulation, clinical and/or biochemical hyperandrogenism and polycystic ovaries on ultrasound (Figure 2). However, as noted, PCOS phenotypes vary widely depending on life stage, genotype, ethnicity and environmental factors, including lifestyle and body weight. Diagnostic investigations must exclude other causes and include thyroid function tests and prolactin and follicle-stimulating hormone (FSH) levels. For diagnosis (...) Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login Purchase options Connect person_outline Login

2011 MJA Clinical Guidelines

55. Effect of levothyroxine on among women with normal thyroid function and thyroid autoimmunity: systematic review and meta-analysis of a randomized clinical trials

Effect of levothyroxine on among women with normal thyroid function and thyroid autoimmunity: systematic review and meta-analysis of a randomized clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr (...) outcome(s) Example: 1st author, year of publication, language, journal. ">Data to be extracted: other as well as a to meta-analysis of pre-clinical studies are available. Example: A meta‐analysis will be performed for all outcome measures reported in 10 or more articles. For subgroup analysis a minimum of 8 studies per subgroup is required. If meta‐analysis is not possible, data will be reported through a descriptive summary. ">Planned approach Example: number of metastases: standardized mean

2018 PROSPERO

56. A Summary of New Findings on the Biological Effects of Selenium in Selected Animal Species—A Critical Review (PubMed)

A Summary of New Findings on the Biological Effects of Selenium in Selected Animal Species—A Critical Review Selenium is an essential trace element important for many physiological processes, especially for the functions of immune and reproductive systems, metabolism of thyroid hormones, as well as antioxidant defense. Selenium deficiency is usually manifested by an increased incidence of retention of placenta, metritis, mastitis, aborts, lowering fertility and increased susceptibility

Full Text available with Trip Pro

2017 International journal of molecular sciences

57. Childhood Thyroid Cancer Treatment (PDQ®): Health Professional Version

Childhood Thyroid Cancer Treatment (PDQ®): Health Professional Version Childhood Thyroid Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. Search database Search term Search NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. PDQ Cancer Information Summaries [Internet (...) by a dominantly inherited or de novo gain-of-function mutation in the RET proto-oncogene associated with multiple endocrine neoplasia (MEN) type 2, either MEN2A or MEN2B, depending on the specific mutation.[ ] When occurring in patients with the MEN syndromes, thyroid cancer may be associated with the development of other types of malignant tumors. (Refer to the section of the PDQ summary on for more information.) Family history. For thyroid carcinomas of follicular cells, only 5% to 10% are familial cancers

2018 PDQ - NCI's Comprehensive Cancer Database

58. Childhood Thyroid Cancer Treatment (PDQ®): Patient Version

Childhood Thyroid Cancer Treatment (PDQ®): Patient Version Childhood Thyroid Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. Search database Search term Search NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. PDQ Cancer Information Summaries [Internet]. Bethesda (MD (...) ): ; 2002-. Search term Childhood Thyroid Cancer Treatment (PDQ®) Patient Version PDQ Pediatric Treatment Editorial Board . Published online: March 15, 2019. Created: January 11, 2018 . This PDQ cancer information summary has current information about the treatment of childhood thyroid cancer. It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care. Editorial Boards write the PDQ cancer information

2018 PDQ - NCI's Comprehensive Cancer Database

59. Thyroid Cancer Treatment (PDQ®): Health Professional Version

Thyroid Cancer Treatment (PDQ®): Health Professional Version Thyroid Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. Search database Search term Search NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. PDQ Cancer Information Summaries [Internet]. Bethesda (MD (...) ): ; 2002-. Search term Thyroid Cancer Treatment (Adult) (PDQ®) Health Professional Version PDQ Adult Treatment Editorial Board . Published online: February 6, 2019. This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of adult thyroid cancer. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care

2018 PDQ - NCI's Comprehensive Cancer Database

60. Thyroid Cancer Screening (PDQ®): Patient Version

Thyroid Cancer Screening (PDQ®): Patient Version Thyroid Cancer Screening (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. Search database Search term Search NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): ; 2002-. Search (...) term Thyroid Cancer Screening (PDQ®) Patient Version PDQ Screening and Prevention Editorial Board . Published online: February 7, 2018. Created: February 7, 2018 . This PDQ cancer information summary has current information about the screening of thyroid cancer. It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care. Editorial Boards write the PDQ cancer information summaries and keep them up

2018 PDQ - NCI's Comprehensive Cancer Database

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>